Recombinant Human Anti-FAS x Human Anti-CSPG4 Bispecific Antibody (IgG-Fv) (BSGV-H325)

Recombinant Anti-FAS x Anti-CSPG4 Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-FAS antibody variable domain is fused to the C terminal of an IgG of anti-CSPG4 antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can induce targeted apoptosis. It is designed for the research of Melanoma therapy.

Datasheet INQUIRY

Specifications

Targets

FAS & CSPG4

Type

IgG-Fv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Melanoma

Targets

Target 1

FAS

Gene ID

355

UniProt ID

P25445

Alternative Names

APT1; CD95; FAS1; APO-1; FASTM; ALPS1A; TNFRSF6; FAS; Fas cell surface death receptor

Target 2

CSPG4

Gene ID

1464

UniProt ID

Q6UVK1

Alternative Names

NG2; Neuron-glial antigen 2; Melanoma-associated chondroitin sulfate proteoglycan; chondroitin sulfate proteoglycan 4; CSPG4; MCSP; MCSPG; MSK16; HMW-MAA; MEL-CSPG

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-FAS x Human Anti-CSPG4 Bispecific Antibody (IgG-Fv) (BSGV-H325). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-FAS x Human Anti-CSPG4 Bispecific Antibody (IgG-Fv) (CAT#: BSGV-H325)

Specifications

Targets

Customer Reviews and Q&As